GENERIC NAME OF THE MEDICINAL PRODUCT:

A. Tacrolimus Capsules IP 0.5mg
B. Tacrolimus Capsules IP 1mg
C. Tacrolimus Capsules IP 2mg
D. Tacrolimus Capsules IP 5mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

A. Tacrolimus Capsules IP 0.5mg
Each hard gelatin Capsule contains:
Tacrolimus IP
Equivalent to Anhydrous Tacrolimus …….0.5mg
Excipients…………………………………..q.s.
Approved colours used in capsule shell.

B. Tacrolimus Capsules IP 1mg
Each hard gelatin Capsule contains:
Tacrolimus IP
Equivalent to Anhydrous Tacrolimus …….1mg
Excipients…………………………………...q.s.
Approved colours used in capsule shell.


C. Tacrolimus Capsules IP 2mg
Each hard gelatin Capsule contains:
Tacrolimus IP
Equivalent to Anhydrous Tacrolimus …….2mg
Excipients…………………………………...q.s.
Approved colours used in capsule shell.

D. Tacrolimus Capsules IP 5mg
Each hard gelatin Capsule contains:
Tacrolimus IP
Equivalent to Anhydrous Tacrolimus …….5mg
Excipients…………………………………...q.s.
Approved colours used in capsule shell.

THERAPEUTIC INDICATIONS:

Tacrolimus is used together with other medicines to prevent the body from rejecting a transplanted organ (eg, kidney, liver, heart, or lung). This medicine may be used with steroids, azathioprine, basiliximab, or mycophenolate mofetil. Tacrolimus belongs to a group of medicines known as immunosuppressive agents.

CAUTION & SCHEDULE:

CAUTION: SWALLOW WHOLE DO NOT CHEW OR CRUSH
SCHEDULE: SCHEDULE H PRESCRIPTION: WARNING: NOT TO BE SOLD BY RETAIL WITHOUT THE PRESCRIPTION OF A NEPHROLOGIST.
IT IS DANGEROUS TO TAKE THIS PREPARATION EXCEPT UNDER MEDICAL SUPERVISION.

STORAGE & DOSAGE:

Storage: Store below 30 °C.
Protect from Light.
Do not refrigerate.
Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
Dosage: As directed by the Nephrologist.

Tacrolimus Capsules IP 1mg Technical Specification:

Product Name:Tacrolimus Capsules IP 1mg
Brand Name:TACROTAJ
Strength:0.5mg, 1mg, 2mg, 5mg
Dosage Form:Hard Gelatin Capsules
Route of Administration:Via Oral Route
Packing:10s, 30s, 100s, 500s
Pack Insert/Leaflet:PIL (Patient Information Leaflet)
Documents:COA, MOA, Stability Studies, GMP
Therapeutic use:Immunosuppressants
Indication: Tacrolimus is used together with other medicines to prevent the body from rejecting a transplanted organ (eg, kidney, liver, heart, or lung). This medicine may be used with steroids, azathioprine, basiliximab, or mycophenolate mofetil. Tacrolimus belongs to a group of medicines known as immunosuppressive agents.
Storage:Store below 30 °C. Protect from Light. Do not refrigerate.

GENERIC NAME OF THE MEDICINAL PRODUCT:

  • Tacrolimus Capsules IP 1mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

  • Tacrolimus Capsules IP 1mg
    Each hard gelatin Capsule contains:
    Tacrolimus IP
    Equivalent to Anhydrous Tacrolimus …….1mg
    Excipients…………………………………..q.s.
    Approved colours used in capsule shell.

THERAPEUTIC INDICATIONS:

Tacrolimus is used together with other medicines to prevent the body from rejecting a transplanted organ (eg, kidney, liver, heart, or lung). This medicine may be used with steroids, azathioprine, basiliximab, or mycophenolate mofetil. Tacrolimus belongs to a group of medicines known as immunosuppressive agents.

CAUTION & SHEDULE:

CAUTION:  SWALLOW WHOLE DO NOT CHEW OR CRUSH

SCHEDULE: SCHEDULE H PRESCRIPTION: WARNING: NOT TO BE SOLD BY RETAIL WITHOUT THE PRESCRIPTION OF A Nephrologist.

IT IS DANGEROUS TO TAKE THIS PREPARATION EXCEPT UNDER MEDICAL SUPERVISION.

STORAGE & DOSAGE:

Storage: Store below 30 °C. Protect from Light. Do not refrigerate.

Read enclosed leaflet before use.

Keep medicine out of reach of children.

Dosage: As directed by the Nephrologist.